4.7 Article

FLNA genomic rearrangements cause periventricular nodular heterotopia

Journal

NEUROLOGY
Volume 78, Issue 4, Pages 269-278

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e31824365e4

Keywords

-

Funding

  1. Nancy Lurie Marks family foundation
  2. Harvard-MIT Health Sciences and Technology and Beth Israel Deaconess Medical Center
  3. Pfizer, Inc.
  4. Merck and Co., Inc.
  5. NINDS [RO1 NS35129]
  6. Manton Center for Orphan Disease Research
  7. ISS [PRE 178/07 COR-F]
  8. SPARC from the Broad Institute of Harvard and Massachusetts Institute of Technology
  9. EU [LSH-2005-2.1.3-2]
  10. Nancy Lurie Marks Foundation
  11. BC Children's Hospital Foundation, Vancouver, Canada
  12. Biocodex
  13. Eisai Inc.
  14. Japanese Epilepsy Society
  15. Weill Cornell Medical College in Qatar
  16. Italian Ministry of Health
  17. European Community Sixth Framework Thematic Priority Life Sciences, Genomics and Biotechnology for Health
  18. Italian Ministry of Education, University and Research
  19. Tuscany Region
  20. Telethon Foundation
  21. Mariani Foundation
  22. Autism Consortium
  23. Merck Foundation
  24. McKnight Foundation
  25. Generation Health
  26. NIH (NINDS/NIMH)
  27. NLM Family Foundation
  28. Simons Foundation

Ask authors/readers for more resources

Objective: To identify copy number variant (CNV) causes of periventricular nodular heterotopia (PNH) in patients for whom FLNA sequencing is negative. Methods: Screening of 35 patients from 33 pedigrees on an Affymetrix 6.0 microarray led to the identification of one individual bearing a CNV that disrupted FLNA. FLNA-disrupting CNVs were also isolated in 2 other individuals by multiplex ligation probe amplification. These 3 cases were further characterized by high-resolution oligo array comparative genomic hybridization (CGH), and the precise junctional breakpoints of the rearrangements were identified by PCR amplification and sequencing. Results: We report 3 cases of PNH caused by nonrecurrent genomic rearrangements that disrupt one copy of FLNA. The first individual carried a 113-kb deletion that removes all but the first exon of FLNA. A second patient harbored a complex rearrangement including a deletion of the 3' end of FLNA accompanied by a partial duplication event. A third patient bore a 39-kb deletion encompassing all of FLNA and the neighboring gene EMD. High-resolution oligo array CGH of the FLNA locus suggests distinct molecular mechanisms for each of these rearrangements, and implicates nearby low copy repeats in their pathogenesis. Conclusions: These results demonstrate that FLNA is prone to pathogenic rearrangements, and highlight the importance of screening for CNVs in individuals with PNH lacking FLNA point mutations. Neurology (R) 2012;78:269-278

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available